Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DDX3 interacting lncRNA 1 (DDX3ILA1, also known as TCONS_00012883) is a long non-coding RNA identified in humans and located on chromosome 22[1]. LncRNAs like DDX3ILA1 do not encode proteins but act as molecular scaffolds or regulators, often influencing gene expression and cellular processes[2][6][8]. Specifically, DDX3ILA1 is reported to promote proliferation and metastasis in colorectal cancer through interaction with proteins such as DDX3, YY1, and the PI3K-AKT signaling axis[3][7]. Though it is biologically significant and disease-relevant, it is not conventionally classified as a direct therapeutic target, receptor, enzyme, or transporter[5][7]. Current evidence does not link DDX3ILA1 to any approved drug interactions or use as a clinical biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DDX3 interacting long non-coding RNA 1 (DDX3ILA1).